Back to catalogue
№ 404 42 filings · 2021-10-20 → 2026-10-16

SYSTEM1 GROUP PLC

SYS1
Media Share price 340p Market cap £44m Overall fit 475 /1000

Strong operating leverage (87% GM, platform model) and clean balance sheet (£11m net cash) partially offset by only indirect AI-receiver exposure, flat multi-year revenue trajectory, and share price already pricing in bid dynamics 7% above the final offer. Interesting situation but doesn't fully capture the AI-receiver thesis.

Fair value range 320p–420p Mid case · £47m
Absolute upside +5.8% vs current market cap
Conviction 3/5 confidence in fair call
Supports the call
  • Takeover Code-governed profit forecasts with reporting accountant opinions
  • Multiple valuation methods converge around 350-400p midpoint
  • Hard reference point from Brave Bison final offer at 327p
Limits the call
  • Standalone fair value depends on whether flat revenue trajectory breaks upward
  • Share price distorted by live bid dynamics — downside risk if deal lapses
Methodology

Blended forward P/E and EV/EBITDA with takeover anchor

In one line · bull case

Scalable 87%-GM marketing-prediction platform with proprietary emotion database and strong operating leverage, currently in a contested takeover situation that provides both a near-term price anchor and binary optionality.

In one line · biggest risk

Brave Bison bid lapses without a counter-bid, exposing a stock that re-rated from 198p pre-offer to 350p back to standalone fundamentals on a flat revenue trajectory.

Drivers
AI beneficiary 48 /100
Owns proprietary 18m-emotion-response dataset with AI training value and launched TYA Screen AI tool, but core business is research methodology — not a pure picks-and-shovels AI beneficiary.
Operating leverage 78 /100
87% gross margin, largely fixed cost base; 5M FY27 showed PBT rising 7x on 11% revenue growth — textbook operating leverage.
Earnings vs expectations 55 /100
Material FY26 guidance cut (Sep 2025) offset by two consecutive FY27 PBT upgrades — net neutral to slightly positive.
Growth momentum 42 /100
Revenue flat 3 years running (~£37m); FY27 guidance implies ~5% growth; Innovation and US showing early momentum but not yet in headline numbers.
Moat 52 /100
Proprietary emotion database and methodology provide differentiation but client NRR of 72-80% suggests moat is narrower than ideal.
Earnings quality 72 /100
Clean reporting, strong cash conversion (FY26 FCF £0.8m on £1.3m net income after bonus payment timing), takeover-code-audited forecasts.
Management quality 48 /100
Founder exited via sale to hostile bidder; multiple AGM resolutions received 46-48% against votes; governance disputes evident.
Cyclicality 55 /100
Marketing research spend is discretionary and cyclical; US tariff disruption in H1 FY26 demonstrated sensitivity to macro.
Leverage 10 /100
Net cash of £11.2m, no debt, £1.5m unused overdraft facility — fortress balance sheet.
Value-trap signals · 4
  • Flat revenue £37m for three consecutive years
  • Platform Net Revenue Retention of 72-80% indicates existing client contraction
  • Governance disputes with ~50% votes against key AGM resolutions
  • Founder exited to the hostile bidder

SYSTEM1 GROUP PLC (SYS1) — Investment Research Note

Executive summary

System1 operates a marketing decision-making platform that uses emotion-measurement methodology and a proprietary database of 18m+ human emotional responses to predict and improve advertising, innovation and brand effectiveness, serving 48 of the world's top 100 brands by media spend. The period 2022-2026 saw a strategic pivot from bespoke consultancy to a scalable "Test Your" automated platform, with Platform Revenue growing from £17m in FY23 to £35.5m in FY26 (now 96% of revenue), gross margins expanding to 87-88%, and powerful operating leverage emerging in 5M FY27 (adjusted PBT £2.1m vs £0.3m prior year on 11% revenue growth) 2026-09-24 trading update. The single most important valuation point today is that System1 is in a live Takeover Code offer period: Brave Bison (holding 28%) has made a final offer of 327p/share (£43.1m, 20.4x FY26A operating profit), which the board has rejected and is being contested — the current 350p share price trades 7% above the "final" offer, implying either rejection confidence or hope for a counter-bidder.

Fair value estimate

Range: 320p – 420p per share, implying market cap of £41m – £53m. Midpoint ~370p (£47m).

Methodology — blended approach:

  • Earnings multiple (primary): FY27 Adjusted PBT guidance of £5.0m 2026-09-24 trading update. Applying ~27% effective tax = net income ~£3.65m, or 29p diluted EPS. At 12-15x forward P/E (reasonable for a scalable platform with 87% GM but minimal growth guidance for FY27 topline), this implies 345-430p.
  • EV/EBITDA cross-check: FY27E adjusted EBITDA ~£6-6.5m; with £11.2m net cash, EV at 350p is ~£32.7m → 5.0-5.5x EV/EBITDA. Peer group marketing/data companies trade 8-12x; a 7-8x multiple implies EV £42-52m plus cash = 420-500p (upside case).
  • Takeover anchor: Brave Bison's final offer at 327p (though 20.4x FY26A operating profit looks high optically because FY26 was depressed; applied to FY27E ~£4m operating profit = 10.8x, which is cheap).

Vs. latest disclosed market cap of £43.9m, the midpoint implies ~6% upside; the range spans -9% to +20%.

Sector context

  • ICB classification confirmed: Consumer Discretionary / Media. System1 is a marketing-insight/data platform — a specialised research technology business rather than a traditional media company.
  • Quality/growth/leverage profile: Gross margin (87%) is well above typical media peers; growth profile is modest (FY27 revenue guidance in line with consensus, PBT upgrade driven by cost not revenue); balance sheet (net cash £11m, no debt) is substantially stronger than typical sector peers.
  • Peers: Kantar (private), YouGov (LSE: YOU), Next Fifteen (LSE: NFC) in UK insight/data; Brave Bison (LSE: BBSN) — the actual bidder — operating a similar platform-plus-services model.

Investment thesis (3 bullets)

  1. Live takeover situation creates asymmetric optionality. Brave Bison owns 28% and has made a "final" offer at 327p; the board is contesting but under Takeover Code dynamics the share price should either settle at the deal value or require a counter-bidder. The 350p current price suggests market participants expect either (a) a higher final offer following further pressure, or (b) standalone value above the bid 2026-10-16 shareholder letter, 2026-07-30 offer announcement.
  2. Operating leverage is now demonstrable and material. 5M FY27 adjusted PBT of £2.1m vs £0.3m prior year on just 11% revenue growth; the full-year PBT upgrade from £4.2m to £5.0m (19%) came entirely from cost optimisation (£1m annualised savings realised in H2 FY26, further efficiencies in FY27) at 87% gross margin. Each incremental £1m of revenue drops substantially to profit 2026-09-24 trading update, 2026-07-08 FY26 results.
  3. Scalable, high-quality platform with blue-chip client concentration improving. 635 clients, 48 of top 100 global advertisers, 12-month platform NRR improved to 80% (from 72%), US now largest region (+16% YoY), new TYA Screen AI product trained on 18m emotional responses launched Aug 2026 with "encouraging" client traction 2026-09-10 trading update.

Key risks (3 bullets)

  1. Takeover outcome binary. If Brave Bison's bid lapses and no counter-bid emerges, the standalone equity could de-rate materially — the share price has already run from ~198p pre-bid to 350p, so unwind risk is significant 2026-07-30 offer announcement.
  2. Growth has stalled at the revenue line. FY26 revenue was flat vs FY25 (£37.0m vs £37.4m); FY27 guidance is "in line with consensus" at £38.8m — essentially 5% growth. The PBT upgrade story is cost-driven, not revenue-driven. Platform NRR of 72-80% means System1 is losing ~20-28% of existing client platform spend annually, offset only by new wins 2026-07-08 FY26 results, 2026-09-10 trading update.
  3. Governance concerns and small-cap illiquidity. FY26 AGM resolutions 13, 14, 15 (pre-emption disapplications and buyback) all failed to carry; resolutions 2 (remuneration), 5 (Chairman re-election) and 12 (allotment authority) received 46-48% against. Founder John Kearon exited by selling to the bidder, signalling internal divisions. £43.9m market cap with 12.7m shares outstanding limits institutional investability 2026-09-25 AGM result; 2026-07-30 offer announcement.

Operating leverage

System1's economics exhibit high operating leverage: FY26 gross margin was 87% on direct costs of just £4.7m against revenue of £37.0m, meaning virtually all of the £32.3m gross profit is available to cover a largely fixed cost base of ~£30m (salaries ~65% of opex, with 184 FTE at year-end, plus £4.5m FY26 product/tech investment). The 5M FY27 result is the cleanest demonstration: on 11% revenue growth and marginally lower overhead expenditure, adjusted PBT rose from £0.3m to £2.1m — effectively the entire incremental gross profit dropped through 2026-09-24 trading update. On that basis, a 10-20% revenue beat above the £38.8m FY27 consensus (incremental £3.9-7.8m revenue × 87% GM = £3.4-6.8m incremental gross profit) would plausibly add £3-6m to operating profit — i.e. more than doubling the upgraded £5.0m FY27 PBT guidance. The constraint is that the revenue line itself has been remarkably range-bound (£37m three years running), so leverage exists but requires a catalyst (US growth, Innovation, TYA Screen adoption) to activate.

Value-trap signals

  • Flat revenue for three consecutive years (FY24 £30m → FY25 £37.4m → FY26 £37.0m → FY27E £38.8m); the FY25 jump may represent a one-off repositioning rather than durable growth.
  • Platform Net Revenue Retention of 72-80% indicates meaningful churn/contraction in existing-client spend.
  • Repeated guidance pattern of H1 disappointment followed by H2 recovery (FY26 H1 was weak, Q1 FY26 trading update in Sept 2025 cut full-year guidance materially).
  • Governance disputes — multiple resolutions failing at FY26 AGM and the founder exiting via the bidder suggests shareholder dissatisfaction with standalone trajectory.

Earnings vs. expectations

  • FY25 (Apr 2025 trading update): Revenue £37.4m vs consensus implied ~£36-37m — met/slightly beat; PBT £5.3m — beat.
  • FY26 Q2 (Sep 2025 trading update): Guidance cut materially — FY26 revenue to be "broadly in line with £37m FY25" vs prior £42.1m consensus; Adj PBT guided £2.0-2.5m vs £5.8m consensus — major miss on guidance reset.
  • FY26 full year (Apr 2026 trading update): Revenue £37m, Adj PBT £2.1m — in line with the reset guidance.
  • FY27 (Sept 2026 trading update): Adj PBT guidance raised twice — from £4.2m consensus to £4.2m to £5.0m — successive beats on the cost line.
  • Pattern: Material miss in FY26 followed by positive cost-driven surprises in FY27 to date. Revenue remains the question mark; profits are over-delivering.

Conviction

Rating: 3 — moderate.

Anchoring factors: (i) High-quality disclosed financials, Takeover Code reporting accountant and financial adviser opinions on the FY27 forecast provide unusual assurance; (ii) Multiple valuation methodologies cluster in a tight band around 320-420p; (iii) The live bid at 327p provides a hard floor-ish reference.

Limiting factors: (i) The share price is distorted by takeover dynamics; standalone fair value estimation is sensitive to whether you believe the revenue line can grow or stays flat; (ii) FY27 PBT guidance has been upgraded twice but the revenue line has not — difficult to assess sustainability of margin improvement if it isn't accompanied by top-line.


Filings consulted · 55

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-10-16Posting OF Shareholder Letter2026-10-16_9827897_posting-of-shareholder-letter.md0.85
  2. 2026-09-25Result OF Agm2026-09-25_9792365_result-of-agm.md0.30
  3. 2026-09-24Trading Update2026-09-24_9787954_trading-update.md0.85
  4. 2026-09-24Replacement Trading Update2026-09-24_9789226_replacement-trading-update.md0.85
  5. 2026-09-105M Fy27 Trading Update2026-09-10_9764270_5m-fy27-trading-update.md0.85
  6. 2026-08-25Annual Report And Notice OF Agm2026-08-25_9739786_annual-report-and-notice-of-agm.md0.95
  7. 2026-07-30Offer For System1 Group Plc2026-07-30_9694688_offer-for-system1-group-plc.md0.80
  8. 2026-07-08Final Results2026-07-08_9657186_final-results.md1.00
  9. 2026-07-02Notice OF Investor Presentation2026-07-02_9648447_notice-of-investor-presentation.md0.70
  10. 2026-04-21Q4 And Full Year Trading Update2026-04-21_9529265_q4-and-full-year-trading-update.md0.85
  11. 2026-03-16Trading Update2026-03-16_9474645_trading-update.md0.72
  12. 2026-01-20Trading Update2026-01-20_9367655_trading-update.md0.72
  13. 2025-12-02Interim Results2025-12-02_9269009_interim-results.md0.77
  14. 2025-10-22Trading Update2025-10-22_9185828_trading-update.md0.72
  15. 2025-10-14Capital Markets Day2025-10-14_9169620_capital-markets-day.md0.62
  16. 2025-09-24Result OF Agm2025-09-24_9129409_result-of-agm.md0.20
  17. 2025-09-23Trading Update2025-09-23_9124491_trading-update.md0.55
  18. 2025-08-27Notice OF Agm2025-08-27_9076250_notice-of-agm.md0.20
  19. 2025-07-09Trading Update2025-07-09_8969921_trading-update.md0.55
  20. 2025-07-09Final Results2025-07-09_8969920_final-results.md0.65
  21. 2025-04-23Trading Statement2025-04-23_8840604_trading-statement.md0.55
  22. 2025-01-21Trading Update2025-01-21_8697738_trading-update.md0.55
  23. 2024-12-03Interim Results2024-12-03_8585940_interim-results.md0.58
  24. 2024-11-28Interim Results Presentation2024-11-28_8577149_interim-results-presentation.md0.58
  25. 2024-10-22Trading Update2024-10-22_8499987_trading-update.md0.55
  26. 2024-09-25Result OF Agm Amp Notice OF H1 Trading Update2024-09-25_8439607_result-of-agm-amp-notice-of-h1-trading-update.md0.38
  27. 2024-08-12Annual Report And Notice OF Agm2024-08-12_8362516_annual-report-and-notice-of-agm.md0.43
  28. 2024-07-12Trading Update2024-07-12_8307748_trading-update.md0.38
  29. 2024-07-12Final Results Correction2024-07-12_8307749_final-results-correction.md0.45
  30. 2024-07-03Final Results2024-07-03_8291616_final-results.md0.45
  31. 2024-06-27Notice OF Final Results And Imc Presentation2024-06-27_8283104_notice-of-final-results-and-imc-presentation.md0.45
  32. 2024-04-16Trading Update2024-04-16_8138773_trading-update.md0.38
  33. 2024-01-24Trading Update2024-01-24_8003180_trading-update.md0.38
  34. 2023-12-12Presentation Via Investor Meet Company2023-12-12_7937436_presentation-via-investor-meet-company.md0.32
  35. 2023-12-06Interim Results2023-12-06_7924070_interim-results.md0.41
  36. 2023-10-24Trading Update2023-10-24_7834557_trading-update.md0.38
  37. 2023-09-27Trading Update2023-09-27_7779884_trading-update.md0.21
  38. 2023-09-27Result OF Agm2023-09-27_7782034_result-of-agm.md0.07
  39. 2023-08-31Annual Report And Notice OF Agm2023-08-31_7726483_annual-report-and-notice-of-agm.md0.24
  40. 2023-07-13Trading Update2023-07-13_7630217_trading-update.md0.21
  41. 2023-04-12Trading Update2023-04-12_7461946_trading-update.md0.21
  42. 2023-04-05Notice OF Trading Update2023-04-05_7429566_notice-of-trading-update.md0.21
  43. 2023-02-28Capital Markets Day2023-02-28_7280953_capital-markets-day.md0.24
  44. 2023-02-23Trading Update2023-02-23_7504958_trading-update.md0.21
  45. 2023-02-14Capital Markets Day2023-02-14_7451684_capital-markets-day.md0.24
  46. 2022-11-30Interim Results2022-11-30_7220898_interim-results.md0.23
  47. 2022-10-25Trading Update2022-10-25_7156719_trading-update.md0.21
  48. 2022-09-28Result OF Agm2022-09-28_7168737_result-of-agm.md0.07
  49. 2022-08-31Notice OF Agm2022-08-31_7162287_notice-of-agm.md0.07
  50. 2022-07-12Quarterly Trading Update2022-07-12_6990842_quarterly-trading-update.md0.21
  51. 2022-04-27Trading Update2022-04-27_7085430_trading-update.md0.21
  52. 2022-02-22Trading Update2022-02-22_6886895_trading-update.md0.21
  53. 2022-02-09Trading Update2022-02-09_6751007_trading-update.md0.21
  54. 2021-11-30Interim Results2021-11-30_6643862_interim-results.md0.23
  55. 2021-10-20Trading Update2021-10-20_6859946_trading-update.md0.21

This research note was authored by a large language model after reading 42 regulatory filings published between 2021-10-20 and 2026-10-16. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.